Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8269012
Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
granted -
US 8268999
Tri-cyclic pyrazolopyridine kinase inhibitors
granted -
US 8268776
Macrocylic oximyl hepatitis C protease inhibitors
granted -
US 8268873
Inhibitors of IMPDH enzyme
granted -
US 8268818
Inhibitors of C-MET and uses thereof
granted -
US 8263651
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
granted -
US 8263657
Inhibitors against the production and release of inflammatory cytokines
granted -
US 8263776
Inhibitors of c-Met protein kinase
granted -
US 8263777
Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
granted -
US 8263549
C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
granted -
US 8263632
Aminopyridine derivatives having Aurora A selective inhibitory action
granted -
US 8257915
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
granted -
US 8258308
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
granted -
US 8252923
Peptidomimetic protease inhibitors
granted -
US 8252787
Protein kinase inhibitors
granted -
US 8247532
Deuterated hepatitis C protease inhibitors
granted -
US 8247563
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
granted -
US 8247421
5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
granted -
US 8242080
Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface
granted -
US 8242160
Inhibitors of ubiquitin E1
granted -
US 8242170
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
granted -
US 8242112
Heterocyclic aspartyl protease inhibitors
granted -
US 8236807
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 8236835
Heterocyclic inhibitors of stearoyl-CoA desaturase
granted